Affordable Access

Nuclear hormone receptor variants: their role in malignancy and progression to hormone resistance in cancer.

Authors
Type
Published Article
Journal
Anti-Cancer Drugs
0959-4973
Publisher
Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins
Publication Date
Volume
1
Issue
2
Pages
127–132
Identifiers
PMID: 2131044
Source
Medline

Abstract

Statistics

Seen <100 times